Literature DB >> 25266211

Risk factors: familial aggregation of ESRD in Europeans-is it in the genes?

Barry I Freedman1, Todd W Robinson1.   

Abstract

A new population-based study of a Norwegian registry containing data on more than 5 million individuals has confirmed the existence of powerful familial clustering of complex aetiologies of end-stage renal disease. Novel strategies for identifying additional nephropathy risk genes will benefit from such large familial registries.

Entities:  

Mesh：

Year:  2014        PMID： 25266211     DOI： 10.1038/nrneph.2014.181

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


  10 in total

1.  Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors:  Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal:  Science       Date:  2010-07-15       Impact factor: 47.728

2.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

Authors:  E R Seaquist; F C Goetz; S Rich; J Barbosa
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

Review 3.  The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.

Authors:  Barry I Freedman; Jeffrey B Kopp; Carl D Langefeld; Giulio Genovese; David J Friedman; George W Nelson; Cheryl A Winkler; Donald W Bowden; Martin R Pollak
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

Review 4.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Authors:  Barry I Freedman; Karl Skorecki
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

5.  Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome.

Authors:  Sheila Santín; Gemma Bullich; Bárbara Tazón-Vega; Rafael García-Maset; Isabel Giménez; Irene Silva; Patricia Ruíz; José Ballarín; Roser Torra; Elisabet Ars
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-17       Impact factor: 8.237

Review 6.  Hereditary interstitial kidney disease.

Authors:  Anthony J Bleyer; P Suzanne Hart; Stanislav Kmoch
Journal:  Semin Nephrol       Date:  2010-07       Impact factor: 5.299

7.  Familial clustering of ESRD in the Norwegian population.

Authors:  Rannveig Skrunes; Einar Svarstad; Anna Varberg Reisæter; Bjørn Egil Vikse
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-04       Impact factor: 8.237

8.  A single nucleotide polymorphism within the acetyl-coenzyme A carboxylase beta gene is associated with proteinuria in patients with type 2 diabetes.

Authors:  Shiro Maeda; Masa-aki Kobayashi; Shin-ichi Araki; Tetsuya Babazono; Barry I Freedman; Meredith A Bostrom; Jessica N Cooke; Masao Toyoda; Tomoya Umezono; Lise Tarnow; Torben Hansen; Peter Gaede; Anders Jorsal; Daniel P K Ng; Minoru Ikeda; Toru Yanagimoto; Tatsuhiko Tsunoda; Hiroyuki Unoki; Koichi Kawai; Masahito Imanishi; Daisuke Suzuki; Hyoung Doo Shin; Kyong Soo Park; Atsunori Kashiwagi; Yasuhiko Iwamoto; Kohei Kaku; Ryuzo Kawamori; Hans-Henrik Parving; Donald W Bowden; Oluf Pedersen; Yusuke Nakamura
Journal:  PLoS Genet       Date:  2010-02-12       Impact factor: 5.917

9.  The familial risk of end-stage renal disease in African Americans.

Authors:  B I Freedman; B J Spray; A B Tuttle; V M Buckalew
Journal:  Am J Kidney Dis       Date:  1993-04       Impact factor: 8.860

10.  Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy.

Authors:  Marcus G Pezzolesi; Pisut Katavetin; Masahiko Kure; G David Poznik; Jan Skupien; Josyf C Mychaleckyj; Stephen S Rich; James H Warram; Andrzej S Krolewski
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461
  10 in total
  1 in total

1.  A single nucleotide polymorphism in the UMOD promoter is associated with end stage renal disease.

Authors:  Tingyu Chen; Qianliao Wang; Guisen Li; Li Wang
Journal:  BMC Med Genet       Date:  2016-12-09       Impact factor: 2.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.